🏛️ Verified NIH Record • Updated 2026-07-21
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System (NCT06183684)
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Laplace Interventional, Inc
🩺 Plain-English Summary (8th-Grade Level)
The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Who can join: Review the eligibility criteria below.
Location: Tucson Medical Center — Tucson, Arizona
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Tucson Medical Center — Tucson, Arizona
- Kaiser Permanente — San Francisco, California
- Piedmont Hospital — Atlanta, Georgia
- Mayo Clinic — Rochester, Minnesota
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
- Montefiore Medical Center — The Bronx, New York
- University Hospitals, Cleveland Medical Center — Cleveland, Ohio
- Oklahoma Heart Institute — Tulsa, Oklahoma
- Providence Heart Institute — Portland, Oregon
- Vanderbilt University Medical Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (763) 465-9501
Email: clinical@laplaceint.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tricuspid Regurgitation
- TRILUMINATE Pivotal Trial — Birmingham, Alabama
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) — Phoenix, Arizona
- TTVR Early Feasibility Study — Birmingham, Alabama
- Clinical Study of Edwards Cardioband FIT Valve Repair System — Chicago, Illinois
- Laplace Early Feasibility Study - Canada — Ottawa, Ontario
Explore by condition: All Tricuspid Regurgitation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.